Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies

2021 ◽  
pp. 1-6
Author(s):  
Haruka Tsuchiya ◽  
Yukiko Iwasaki ◽  
Hirofumi Shoda ◽  
Yukitoshi Takahashi ◽  
Keishi Fujio
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Glutamate Receptor ◽  
Lupus Erythematosus ◽  
Limbic Encephalitis ◽  
High Dose ◽  
Systemic Lupus ◽  
Intravenous Cyclophosphamide ◽  
Cyclophosphamide Therapy ◽  
Potential Pathogenicity ◽  
Receptor Antibodies

scholarly journals High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: A prospective randomized trial

2010 ◽  
Vol 62 (5) ◽  
pp. 1487-1493 ◽  
Author(s):  
Michelle Petri ◽  
Robert A. Brodsky ◽  
Richard J. Jones ◽  
Douglas Gladstone ◽  
Michael Fillius ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Randomized Trial ◽  
Lupus Erythematosus ◽  
Prospective Randomized Trial ◽  
High Dose ◽  
Systemic Lupus ◽  
Intravenous Cyclophosphamide

scholarly journals High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia

1988 ◽  
Vol 31 (5) ◽  
pp. 693-694 ◽  
Author(s):  
Anne Winkler ◽  
Robert W. Jackson ◽  
Donald S. Kay ◽  
Edith Mitchell ◽  
Sharon Carmignani ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Aplastic Anemia ◽  
Lupus Erythematosus ◽  
High Dose ◽  
Systemic Lupus ◽  
Intravenous Cyclophosphamide ◽  
Cyclophosphamide Treatment
Sign in / Sign up

Export Citation Format

Share Document